Immunyfit Healthtech Pvt Ltd
Immunyfit Healthtech is an investigative physiology platform rooted in systems biology AI and structured scientific knowledge. It delivers personalized, digital, and data-driven assessments and management for autoimmune and gut-immune disorders.
Autoimmune disorders have doubled in prevalence over the past decade, with 20 million patients in India and affecting 3% of the global population currently. Over 60% of patients remain undiagnosed or misdiagnosed due to low awareness, inadequate doctor-patient ratios, and deteriorating environmental and mental stress factors. This complexity strains patients and the healthcare system, with projections indicating that it will impact 5% of the population by 2030.
Our advanced methodologies—predictive analytics, digital biomarkers, healthcare screening, real-time health tracking and remote monitoring, multiomics, and genomics—facilitate early detection, assessment, and evidence-based management and supports patients, doctors, hospitals, and drug research companies achieve better health outcomes.
We are among the first globally to use Biology-First AI for the assessment of autoimmune and gut-immune disorders. Our innovation provides a global competitive advantage in disorder predictive analytics.
Our vision is to drive adoption through patient subscriptions and collaborations with doctors and hospitals, establishing a strong domestic presence before expanding overseas, with a primary focus on Asia and North America.